Products

AG00E993

Name: Paf (c16)
Brand: Angene Chemical
SKU: AG00E993

65154-06-5 | Paf (c16)

Chemical structure of Paf (c16), CAS 65154-06-5

AG00E993

SDS

COA

Price

$0.00

Add to Cart

WARNING This product is not for human or veterinary use.

Request For Quotation

CAS Number	65154-06-5
Catalog Number	AG00E993(AGN-PC-0TFLPZ)
Chemical Name	Paf (c16)
IUPAC Name	[(2R)-2-acetyloxy-3-hexadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
InChI	InChI=1S/C26H54NO7P/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-19-21-31-23-26(34-25(2)28)24-33-35(29,30)32-22-20-27(3,4)5/h26H,6-24H2,1-5H3/t26-/m1/s1
InChI Key	HVAUUPRFYPCOCA-AREMUKBSSA-N
MDL Number	MFCD00043214
Molecular Formula	C12H26NO7P
Molecular Weight	327.3111
SMILES	CCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)C
UNII	42EWD89I80
Synonyms	Platelet activating factor, PAF (C16), 74389-68-7, Platelet-activating factor, C16-PAF, 1-O-Hexadecyl-2-acetyl-sn-glycero-3-phosphocholine, Hag-PC, APRL, Hexadecyl-paf-acether, Platelet-activating factor C16, 1-O-Hexadecyl-platelet-activating factor, PAF C-16, 1-O-Hexadecyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine, 1-O-Hexadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine, 1-Hexadecyl-2-acetyl-glycero-3-phosphocholine, C16-PAF acether, 1-Hexadecyl-2-acetyl-sn-glycero-3-phosphocholine, Blood platelet-activating factor, 1-O-Hexadecyl-2-O-acetyl-sn-glycero-3-phosphocholine, 1-O-Hexadecyl-2-O-acetyl-sn-glycero-3-phosophocholine, UNII-42EWD89I80, Platelet Activating Factor-16, C26H54NO7P, PAF(C16), CHEBI:44811, Platelet-activating factor acether, 42EWD89I80, (2r)-2-acetoxy-3-(hexadecyloxy)propyl 2-(trimethylammonio)ethyl phosphate, MFCD00043214, beta-acetyl-gamma-O-hexadecyl-L-alpha-phosphatidylcholine, Blood platelet-activating factor acether, PC(O-16:0/2:0), 65154-06-5, 3-sn-Phosphatidylcholine, 1-hexadecyl-2-acetyl, 2-Acetyl-1-hexadecyl-sn-glycero-3-phosphocholine, 1-O-Palmityl-2-acetyl-sn-glycero-3-phosphocholine, 3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 7-(acetyloxy)-4-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt, 4-oxide, (7R)-, 3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 7-(acetyloxy)-4-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt, 4-oxide, (R)-, 1-O-Palmityl-2-acetyl-sn-glycero-3-phosphocholine monohydrate, 3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 7-(acetyloxy)-4-hydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (R)-, [3H]PAF, [3H]platelet activating factor, [(2R)-2-acetyloxy-3-hexadecoxypropyl] 2-trimethylazaniumylethyl phosphate, HAGPC, 1-O-hexadecyl PAF, HD-PAF, (2r)-2-(Acetyloxy)-3-(Hexadecyloxy)propyl 2-(Trimethylammonio)ethyl Phosphate, PFS, AC1L33FZ, AC1Q22IK, bloodplatelet-activatingfactor, C16 PAF, PAF C16, SCHEMBL433361, BML3-E03, GTPL1831, GTPL1833, PAF 16, CHEMBL1235246, BDBM85035, C16:0 PAF, platelet-activating factor C-16, DTXSID00225377, HVAUUPRFYPCOCA-AREMUKBSSA-N, PAF (Platelet Activating Factor), HMS1361I10, HMS1791I10, HMS1989I10, HMS3402I10, HMS3648N18, 1975AH, LMGP01020046, AKOS024457347, DB02261, PC(O-18:0), NCGC00161373-01, NCGC00161373-02, NCGC00161373-03, CAS_65154-06-5, LS-157676, B7227, 2-Acetyl-1-alkyl-sn-glycero-3-phosphocholine, 1-Alkyl-2-acetoyl-Sn-glycero-3-phosphocholine, A-8995, 1-O-Hexadecyl-2-acetyl-sn-glycerophosphocholine, 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine, I14-55455, 1-alkyl-2-acetoyl-hexadecyl-glycero-3-phosphorylcholine, 1-O-OCTADECYL-2-ACETYL-SN-GLYCEROL-3-PHOSPHOCHOLINE, UNII-42EWD89I80 component HVAUUPRFYPCOCA-AREMUKBSSA-N, [(2R)-2-acetyloxy-3-hexadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate, C16-02:0 PC, 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine, powder, PAF (from Heart PC), 1-alkyl-2-acetoyl-sn-glycero-3-phosphocholine, powder, C16-02:0 PC, 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine, chloroform, (7R)-7-(Acetyloxy)-4-hydroxy-N,N,N-trimethyl-3,5,9-trioxa-4-phosphapentacosan-1-aminium-4-oxide, (R)-7-(acetyloxy)-4-hydroxy-N,N,N-trimethyl-3,5,9-trioxa-4-phosphapentacosan-1-aminium hydroxide inner salt 4-oxide, 3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 7-(acetyloxy)-4-hydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (7R)- (9CI), 3,5,9-Trioxa-4-phosphapentacosan-1-aminium,7-(acetyloxy)-4-hydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (7R)-, beta-Acetyl-gamma-O-alkyl-L-alpha-phosphatidylcholine from bovine heart lecithin, >=99%, lyophilized powder, beta-Acetyl-gamma-O-alkyl-L-alpha-phosphatidylcholine from bovine heart lecithin, 2 mg/mL in chloroform, ~99%, ethanaminium, 2-[[[[(2R)-2-(acetyloxy)-3-(hexadecyloxy)propyl]oxy]hydroxyphosphinyl]oxy]-N,N,N-trimethyl-, inner salt, PAF acether, PAF-acether, AGEPC, D04FHG, D0H7RM, Platelet activating factor-acether, KST-1A8202, C26-H54-N-O7-P, AR-1A2676, CID108156, Antihypertensive polar renomedullary lipid, Platelet activating factor phosphatidate, Blood platelet activating factor - acether, PAF, 1-O-Alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine, 7787-42-0,

Complexity	546
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	0
Exact Mass	523.364g/mol
Formal Charge	0
Heavy Atom Count	35
Hydrogen Bond Acceptor Count	7
Hydrogen Bond Donor Count	0
Isotope Atom Count	0
Molecular Weight	523.692g/mol
Monoisotopic Mass	523.364g/mol
Rotatable Bond Count	26
Topological Polar Surface Area	94.1A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	6.5

Related Research Chemicals

CERTIFICATE OF ANALYSIS

Chemical Name:	Batch Number:
Chemical Structure:	CAS Registry No:
	Product ID:
	Manufacture Date:
	Storage Temperature:
	Formula:
	Molecular Weight:
	Quantity:

Analysis Data:

Test:

Result:

Conclusion: The above product meets the specifications of Angene.

Analyst:Chase

Date:

Reviewed by:Jessie

Date:

Angene International Limited